Medical Supplies and Services News

Le contrat couvre désormais un total de 11 pays européens Crossject recevra des paiements d’étape pour un montant total pouvant aller jusqu’à un million d’euros, dès l’obtention des autorisations de...

Extended contract now covers a total of 11 European countries Crossject will receive milestone payments of up to €1 million in total, upon marketing authorizations Crossject will sell ZEPIZURE®...

SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET....

Please call me to verify details of the release at 978-460-7074

Crossject annonce le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant d’environ 8 millions d’euros pour renforcer ses sources de financement...

Assemblea Annuale degli Azionisti 2024,inizia un nuovo capitolo della storia di EssilorLuxottica Approvate tutte le delibere proposte dal Consiglio di AmministrazioneDividendo pari a Euro 3,95 per...

Assemblée générale 2024 d’EssilorLuxottica,un nouveau chapitre de l’histoire du Groupe s’ouvre Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 3,95 € par...

EssilorLuxottica 2024 Annual Shareholders’ Meeting,starting a new chapter of the Company’s history All resolutions proposed by the Board of Directors adoptedDividend of Euro 3.95 per share, with...

HUMMELSTOWN, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based...

SINGAPORE, April 30, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the grand...